Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia

Molecular Psychiatry volume 11, pages 459–470 (2006)Cite this article

Abstract

The Anterior Cingulate Cortex (ACC, Brodmans Area 24) is implicated in the pathogenesis of schizophrenia due to its normal functions and connectivity together with reports of structural, morphological and neurotransmitter aberrations within this brain area in the disease state. Two-dimensional gel electrophoresis (2DE) was employed to scan and compare the ACC gray matter proteomes between schizophrenia (n=10) and control (n=10) post-mortem human tissue. This proteomic approach has detected 42 protein spots with altered levels in the schizophrenia cohort, which to our knowledge is the first proteomic analysis of the ACC in schizophrenia. Thirty nine of these proteins were subsequently identified using mass spectrometry and functionally classified into metabolism and oxidative stress, cytoskeletal, synaptic, signalling, trafficking and glial-specific groups. Some of the identified proteins have previously been implicated in the disease pathogenesis and some offer new insights into schizophrenia. Investigating these proteins, the genes encoding these proteins, their functions and interactions may shed light on the molecular mechanisms underlying the heterogeneous symptoms characteristic of schizophrenia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Hempel A, Hempel E, Schonknecht P, Stippich C, Schroder J . Impairment in basal limbic function in schizophrenia during affect recognition. Psychiatry Res 2003; 122: 115–124.

    Article  Google Scholar 

  2. Carter CS, MacDonald III AW, Ross LL, Stenger VA . Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatry 2001; 158: 1423–1428.

    Article  CAS  Google Scholar 

  3. Salgado-Pineda P, Baeza I, Perez-Gomez M, Vendrell P, Junque C, Bargallo N et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 2003; 19 (2 Part 1): 365–375.

    Article  Google Scholar 

  4. Cleghorn JM, Garnett ES, Nahmias C, Brown GM, Kaplan RD, Szechtman H et al. Regional brain metabolism during auditory hallucinations in chronic schizophrenia. Br J Psychiatry 1990; 157: 562–570.

    Article  CAS  Google Scholar 

  5. Quintana J, Wong T, Ortiz-Portillo E, Marder SR, Mazziotta JC . Anterior cingulate dysfunction during choice anticipation in schizophrenia. Psychiatry Res 2004; 132: 117–130.

    Article  Google Scholar 

  6. Carter CS, Mintun M, Nichols T, Cohen JD . Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. Am J Psychiatry 1997; 154: 1670–1675.

    Article  CAS  Google Scholar 

  7. Bouras C, Kovari E, Hof PR, Riederer BM, Giannakopoulos P . Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol (Berlin) 2001; 102: 373–379.

    CAS  Google Scholar 

  8. Chana G, Landau S, Beasley C, Everall IP, Cotter D . Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 2003; 53: 1086–1098.

    Article  Google Scholar 

  9. Benes FM, Vincent SL, Todtenkopf M . The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 2001; 50: 395–406.

    Article  CAS  Google Scholar 

  10. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M . Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex 1992; 2: 503–512.

    Article  CAS  Google Scholar 

  11. Benes FM . Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 2000; 31: 251–269.

    Article  CAS  Google Scholar 

  12. Benes FM, Todtenkopf MS, Taylor JB . Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 1997; 25: 80–92.

    Article  CAS  Google Scholar 

  13. Woo TU, Walsh JP, Benes FM . Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2004; 61: 649–657.

    Article  CAS  Google Scholar 

  14. Kalus P, Senitz D, Lauer M, Beckmann H . Inhibitory cartridge synapses in the anterior cingulate cortex of schizophrenics. J Neural Transm 1999; 106: 763–771.

    Article  CAS  Google Scholar 

  15. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP . Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992; 12: 924–929.

    Article  CAS  Google Scholar 

  16. Coyle JT, Puttfarcken P . Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689–695.

    Article  CAS  Google Scholar 

  17. Jiang L, Lindpaintner K, Li HF, Gu NF, Langen H, He L et al. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Amino Acids 2003; 25: 49–57.

    Article  CAS  Google Scholar 

  18. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684–697, 643.

    Article  CAS  Google Scholar 

  19. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 2000; 5: 142–149.

    Article  CAS  Google Scholar 

  20. Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, Faull RL . Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol. Psychiatry 2000; 5: 85–90.

    Article  CAS  Google Scholar 

  21. Vogt BA, Nimchinsky EA, Vogt LJ, Hof PR . Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J Comp Neurol 1995; 359: 490–506.

    Article  CAS  Google Scholar 

  22. American PA . Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington DC, 1994.

    Google Scholar 

  23. Alexander-Kaufman A, James G, Sheedy D, Harper C, Matsumoto I . Differential protein expression in the prefrontaol white matter of human alcoholics: a proteomics study. Mol Psychiatry 2006; 11: 56–65.

    Article  CAS  Google Scholar 

  24. Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254.

    Article  CAS  Google Scholar 

  25. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC . The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995; 200: 151–154.

    Article  CAS  Google Scholar 

  26. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995; 28: 311–318.

    Article  CAS  Google Scholar 

  27. Fountoulakis M, Hardmeier R, Hoger H, Lubec G . Postmortem changes in the level of brain proteins. Exp Neurol 2001; 167: 86–94.

    Article  CAS  Google Scholar 

  28. Thompson PM, Sower AC, Perrone-Bizzozero NI . Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry 1998; 43: 239–243.

    Article  CAS  Google Scholar 

  29. Maurer I, Zierz S, Moller H . Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 2001; 48: 125–136.

    Article  CAS  Google Scholar 

  30. Klushnik TP, Spunde A, Yakovlev AG, Khuchua ZA, Saks VA, Vartanyan ME . Intracellular alterations of the creatine kinase isoforms in brains of schizophrenic patients. Mol Chem Neuropathol 1991; 15: 271–280.

    Article  CAS  Google Scholar 

  31. Mukerjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H . Impaired antioxidant defense at the onset of psychosis. Schizophr Res 1996; 19: 19–26.

    Article  CAS  Google Scholar 

  32. Kim JJ, Lee SJ, Toh KY, Lee CU, Lee C, Paik IH . Identification of antibodies to heat shock proteins 90 and 70 kDa in patients with schizophrenia. Schizophr Res 2001; 52: 127–135.

    Article  CAS  Google Scholar 

  33. Willson VJ, Graham JG, McQueen IN, Thompson RJ . Immunoreactive aldolase C in cerebrospinal fluid of patients with neurological disorders. Ann Clin Biochem 1980; 17: 110–113.

    Article  CAS  Google Scholar 

  34. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005; 58: 85–96.

    Article  CAS  Google Scholar 

  35. Dror N, Klein E, Karry R, Sheinkman A, Kirsh Z, Mazor M et al. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry 2002; 7: 995–1001.

    Article  CAS  Google Scholar 

  36. Hallmayer J . Chromosomes 1, 2, and 7 workshop. Am J Med Genet 1999; 88: 219–223.

    Article  CAS  Google Scholar 

  37. Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD et al. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet 2000; 9: 1049–1057.

    Article  CAS  Google Scholar 

  38. Molloy GR, Wilson CD, Benfield P, de Vellis J, Kumar S . Rat brain creatine kinase messenger RNA levels are high in primary cultures of brain astrocytes and oligodendrocytes and low in neurons. J Neurochem 1992; 59: 1925–1932.

    Article  CAS  Google Scholar 

  39. Tachikawa M, Fukaya M, Terasaki T, Ohtsuki S, Watanabe M . Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur J Neurosci 2004; 20: 144–160.

    Article  Google Scholar 

  40. Hemmer W, Wallimann T . Functional aspects of creatine kinase in brain. Dev Neurosci 1993; 15: 249–260.

    Article  CAS  Google Scholar 

  41. Jost CR, Van Der Zee CE, In ‘t Zandt HJ, Oerlemans F, Verheij M, Streijger F et al. Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility. Eur J Neurosci 2002; 15: 1692–1706.

    Article  Google Scholar 

  42. Burbaeva G, Savushkina OK, Boksha IS . Creatine kinase BB in brain in schizophrenia. World J Biol Psychiatry 2003; 4: 177–183.

    Article  Google Scholar 

  43. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM . Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem J 1992; 281 (Part 1): 21–40.

    Article  CAS  Google Scholar 

  44. Schwartz PJ, Reaume A, Scott R, Coyle JT . Effects of over- and under-expression of Cu, Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum. Brain Res 1998; 789: 32–39.

    Article  CAS  Google Scholar 

  45. Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT . Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 1998; 155: 1207–1213.

    Article  CAS  Google Scholar 

  46. Zhang XY, Zhou DF, Cao LY, Chen da C, Zhu FY, Wu GY . Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr Res 2003; 62: 245–250.

    Article  Google Scholar 

  47. Dakhale G, Khanzode S, Saoji A, Khobragade L, Turankar A . Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 2004; 49: 205–209.

    Article  Google Scholar 

  48. Thornalley PJ . The glyoxalase system in health and disease. Mol Aspects Med 1993; 14: 287–371.

    Article  CAS  Google Scholar 

  49. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49: 522–530.

    Article  CAS  Google Scholar 

  50. Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel Jr BV, Lohr J et al. Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry 1997; 154: 682–684.

    Article  CAS  Google Scholar 

  51. Di Paolo G, Antonsson B, Kassel D, Riederer BM, Grenningloh G . Phosphorylation regulates the microtubule-destabilizing activity of stathmin and its interaction with tubulin. FEBS Lett 1997; 416: 149–152.

    Article  CAS  Google Scholar 

  52. Zhu J, Zhou K, Hao JJ, Liu J, Smith N, Zhan X . Regulation of cortactin/dynamin interaction by actin polymerization during the fission of clathrin-coated pits. J Cell Sci 2005; 118 (Part 4): 807–817.

    Article  CAS  Google Scholar 

  53. Paulson L, Martin P, Nilsson CL, Ljung E, Westman-Brinkmalm A, Blennow K et al. Comparative proteome analysis of thalamus in MK-801-treated rats. Proteomics 2004; 4: 819–825.

    Article  CAS  Google Scholar 

  54. Mori N, Morii H . SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J Neurosci Res 2002; 70: 264–273.

    Article  CAS  Google Scholar 

  55. Nishiki T, Nihonmatsu I, Tsuhara Y, Kawasaki M, Sekiguchi M, Sato K et al. Distribution of soluble N-ethylmaleimide fusion protein attachment proteins (SNAPs) in the rat nervous system. Neuroscience 2001; 107: 363–371.

    Article  CAS  Google Scholar 

  56. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P . Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53–67.

    Article  CAS  Google Scholar 

  57. Imai C, Sugai T, Iritani S, Niizato K, Nakamura R, Makifuchi T et al. A quantitative study on the expression of synapsin II and N-ethylmaleimide-sensitive fusion protein in schizophrenic patients. Neurosci Lett 2001; 305: 185–188.

    Article  CAS  Google Scholar 

  58. Gray L, Scarr E, Dean B . N-Ethylmaleimide sensitive factor in the cortex of subjects with schizophrenia and bipolar I disorder. Neurosci Lett 2006; 391: 112–115.

    Article  CAS  Google Scholar 

  59. Bordelon JR, Smith Y, Nairn AC, Colbran RJ, Greengard P, Muly EC . Differential localization of protein phosphatase-1{alpha}, {beta} and {gamma}1 isoforms in primate prefrontal cortex. Cereb Cortex 2005; 15: 1928–1937.

    Article  Google Scholar 

  60. Cohen PT . Protein phosphatase 1—targeted in many directions. J Cell Sci 2002; 115 (Part 2): 241–256.

    PubMed  CAS  Google Scholar 

  61. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M et al. Diverse psychotomimetics act through a common signaling pathway. Science 2003; 302: 1412–1415.

    Article  CAS  Google Scholar 

  62. Yang CQ, Kitamura N, Nishino N, Shirakawa O, Nakai H . Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia. Biol Psychiatry 1998; 43: 12–19.

    Article  CAS  Google Scholar 

  63. Moore C, Perry AC, Love S, Hall L . Sequence analysis and immunolocalisation of phosphatidylethanolamine binding protein (PBP) in human brain tissue. Brain Res Mol Brain Res 1996; 37: 74–78.

    Article  CAS  Google Scholar 

  64. Seddiqi N, Bollengier F, Alliel PM, Perin JP, Bonnet F, Bucquoy S et al. Amino acid sequence of the Homo sapiens brain 21-23-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues. J Mol Evol 1994; 39: 655–660.

    Article  CAS  Google Scholar 

  65. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 2002; 82: 1524–1532.

    Article  CAS  Google Scholar 

  66. Ongur D, Drevets WC, Price JL . Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290–13295.

    Article  CAS  Google Scholar 

  67. Cotter D, Mackay D, Landau S, Kerwin R, Everall I . Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58: 545–553.

    Article  CAS  Google Scholar 

  68. Meyer-Franke A, Shen S, Barres BA . Astrocytes induce oligodendrocyte processes to align with and adhere to axons. Mol Cell Neurosci 1999; 14: 385–397.

    Article  CAS  Google Scholar 

  69. Webster MJ, O'Grady J, Kleinman JE, Weickert CS . Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 2005; 133: 453–461.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Tissue was received from the NSW Tissue Resource Centre, which is supported by the University of Sydney, Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD), National Institute of Alcohol Abuse and Alcoholism and NSW Department of Health. This work was supported by grants from the NSW Government BioFirst Award provided to IM and by NISAD, utilizing infrastructure funding from NSW Health.

Author information

Authors and Affiliations

  1. Department of Pathology, The University of Sydney, Sydney, NSW, Australia

    D Clark, I Dedova, S Cordwell & I Matsumoto

  2. Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD), Sydney, NSW, Australia

    D Clark & I Dedova

  3. School of Molecular and Microbial Biosciences, The University of Sydney, Sydney, NSW, Australia

    S Cordwell

Authors
  1. D Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I Dedova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Cordwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I Matsumoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clark, D., Dedova, I., Cordwell, S. et al. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol Psychiatry 11, 459–470 (2006). https://doi.org/10.1038/sj.mp.4001806

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001806

Keywords

This article is cited by

Search

Advanced search

Quick links